APC anti-mouse TER-119/Erythroid Cells Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Day-14 fetal liver cells from a C57BL/6 mouse

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Red Laser (633 nm)

Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation¹, Western blotting¹, complement-mediated cytotoxicity³, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References

(PubMed link indicates BioLegend citation)

1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
2. Vannucchi AM, et al. 2000. Blood 95:2559.
3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
4. Grisendi S, et al. 2005. Nature 437:147. (FC)
5. Bourdeau A, et al. 2007. Blood 109:4220.
6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
7. Heuser M, et al. 2007. Blood 110:1639. (FC)
8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed

Product Citations

1. Yang D, et al. 2022. Cell. 185:1905. PubMed
2. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
3. Koury D, et al. 2017. Int J Parasitol. 10.1016/j.ijpara.2017.05.009. PubMed
4. Wang L, et al. 2018. Bone Res. 6:22. PubMed
5. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
6. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
7. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
8. Ray S, et al. 2020. J Biol Chem. 295:7113. PubMed
9. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
10. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
11. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
12. Li C, et al. 2021. Mol Ther. 29:822. PubMed
13. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
14. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
15. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
16. Lutzmann M, et al. 2019. Cell Rep. 28:2851. PubMed
17. Liu P, et al. 2020. Genome Res. 30:1655. PubMed
18. Nishina T, et al. 2021. Nat Commun. 12:2281. PubMed
19. Yeo S, et al. 2016. Cancer Res . 76: 3397 - 3410. PubMed
20. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
21. Bilodeau M, et al. 2009. PLoS One. 4:e7500. PubMed
22. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
23. Liu S, et al. 2021. Mol Ther. 29:1918. PubMed
24. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
25. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
26. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
27. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
28. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
29. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
30. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
31. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
32. Negretti NM, et al. 2021. Development. 148:. PubMed
33. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
34. Guihard S, et al. 2010. Blood. 115:3686. PubMed
35. Yu VWC, et al. 2017. Cell. 168:944. PubMed
36. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
37. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
38. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
39. Saleiro D, et al. 2022. Nat Commun. 13:1750. PubMed
40. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
41. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
42. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
43. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
44. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
45. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
46. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
47. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
48. Shin JJ, et al. 2020. Cell Rep. 32:108093. PubMed
49. Long JT, et al. 2022. Elife. 11:. PubMed
50. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
51. Li G, et al. 2020. J Clin Invest. 130:1233. PubMed
52. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
53. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
54. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
55. Song J, et al. 2014. Exp Cell Res. 327:123. PubMed
56. Wang H, et al. 2019. J Clin Invest. 129:598. PubMed
57. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
58. Liu W, et al. 2022. J Clin Invest. 132: . PubMed
59. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
60. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
61. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
62. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
63. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
64. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
65. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
66. Maeda K, et al. 2021. Pathogens. 10:. PubMed
67. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
68. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
69. Cambridge E, et al. 2017. Exp Hematol. 45:64-68.e5. PubMed
70. Markworth JF, et al. 2020. JCI Insight. 5:00. PubMed
71. Wang H, et al. 2020. JCI Insight. 5:00. PubMed
72. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
73. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
74. Khoriaty R, et al. 2014. Mol Cell Biol. 34:3721. PubMed
75. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
76. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
77. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
78. Yin Y, et al. 2016. J Biol Chem. 291: 6923 - 6935. PubMed
79. Rowe R, et al. 2016. J Exp Med. 213: 1497 - 1512. PubMed
80. Werner MT, et al. 2020. J Biol Chem. 295:1898. PubMed
81. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
82. Schmidts A, et al. 2020. J Immunother Cancer. 8:. PubMed
83. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
84. Lam J, et al. 2018. Nat Commun. 9:2418. PubMed

RRID

AB_313712 (BioLegend Cat. No. 116211)
AB_313713 (BioLegend Cat. No. 116212)

Antigen Details

Structure

Associated with glycophorin A, 52 kD

Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type

Erythrocytes

Biology Area

Immunology

Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID

104231 View all products for this Gene ID

UniProt

View information about TER-119 on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis